Trump administration plans to distribute 100 million rapid COVID-19 tests to states
Governors are encouraged to use the tests in efforts to reopen schools.
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
The Trump administration has announced a plan to distribute millions of rapid COVID-19 tests to states, with a focus on using the tests to reopen schools.
On Monday (Sept. 28), President Donald Trump said in a news conference that the federal government would soon begin deploying 150 million rapid COVID-19 tests across the country. Of these, 50 million tests would go to support "vulnerable communities," such as those in nursing homes, while 100 million tests would go to states "to support efforts to reopen their economies and schools immediately and fast as they can," Trump said.
The rapid test, which is made by Abbott, is an antigen test, which looks for specific viral proteins, and can provide results in 15 minutes. Known as the Abbott BinaxNOW COVID-19 Ag Card, the test is a simple nasal swab that requires no lab equipment. The test received emergency use authorization from the U.S. Food and Drug Administration in late August, Live Science previously reported. The test is authorized for use in point-of-care settings, that is, at the time patients receive care. The Trump administration recently awarded a $760 million contract to Abbott for delivery of its rapid tests, according to a statement from the U.S. Department of Health & Human Services.
To start, 6.5 million tests will be shipped to states this week. Although governors will be allowed to use the tests as they see fit, they are encouraged to use them in schools, officials said.
"We expressed a hope to all the governors today that they would particularly use these Abbott Binax tests to open up American's schools and to keep them open," Vice President Mike Pence said at the conference.
There are about 56 million school-aged children in the United States, and 3.7 million teachers, according to the National Center for Educational Statistics. Trump specifically mentioned using the tests for teachers, saying the testing efforts would "allow every state to, on a very regular basis, test every teacher who needs it."
Originally published on Live Science.
Get the world’s most fascinating discoveries delivered straight to your inbox.

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.
